Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
ASP Isotopes, Inc. ( (ASPI) ) has issued an update.
On January 26, 2026, ASP Isotopes Inc. agreed to invest in biotechnology company Opeongo, Inc. by purchasing 4,356,918 shares of Opeongo’s Series Seed-1 preferred stock at $2.2952 per share, gaining a significant equity stake in a business developing extracellular matrix-modulating therapeutics targeting fibrosis, inflammation and cancer. As part of the deal, ASP Isotopes secured conversion, voting, anti-dilution and veto rights, the ability for preferred holders to elect a dedicated board director, and a commitment to negotiate a supply agreement giving it a right of first offer on medical isotope supply for any future Opeongo pharmaceutical products, while related-party executives Paul Mann and Todd Wider took on board roles under new governance, rights and transfer-restriction arrangements that deepen ASP Isotopes’ strategic alignment with Opeongo and expand its potential role in the biotech value chain.
The most recent analyst rating on (ASPI) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on ASP Isotopes, Inc. stock, see the ASPI Stock Forecast page.
Spark’s Take on ASPI Stock
According to Spark, TipRanks’ AI Analyst, ASPI is a Neutral.
The score is held back primarily by weak financial fundamentals—net losses and high leverage—despite rapid revenue growth. Technicals are supportive in the near term, but valuation remains challenged due to lack of profitability. Earnings-call and recent corporate events add moderate upside potential (new facilities, contracts, and acquisition integration), but execution and regulatory risks keep the overall rating in the mid-range.
To see Spark’s full report on ASPI stock, click here.
More about ASP Isotopes, Inc.
ASP Isotopes Inc. is a Delaware-based company operating in the isotopes sector, with a focus that includes supplying medical isotopes for use in pharmaceutical products, positioning itself at the intersection of advanced materials and life sciences applications.
Average Trading Volume: 6,360,932
Technical Sentiment Signal: Buy
Current Market Cap: $993.4M
For detailed information about ASPI stock, go to TipRanks’ Stock Analysis page.